| Descriptions | Industry | Location | Stage | Financial status | Funding needed |
|---|---|---|---|---|---|
| Breakthrough Therapy for Auto-Immune Diseases; Multiple Indication Product: Completed Phase II Trial in T1D, ready to enter Phase III | BioTech | Cedar Knolls, NJ | Series A+ | Seed in progress | $60M |
| Global leading implantable medical solutions | BioTech | Fremont, CA | Series B | Closed series B | |
| Novel stem cell technology targeting unmet medical needs | BioTech | Fremont, CA | Seed | Pre-A in progress |
Zeda Health
APStem
Contact us to unlock more details
Global leading implantable medical solutions
Zeda, Inc. Closes $52 Million Series B Financing Round
Learn MoreContact us to unlock more details